Bringing innovation to patients around the world

iStock-1131857558-home

Our Mission

To transform the lives of patients living with autoimmune diseases.

Learn More

Our Pipeline

Rapidly advancing a deep portfolio of innovative autoimmune therapeutics that continues to expand through our successful business development strategy.

Learn More

Latest News

January 11, 2023

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

Read More

November 7, 2022

Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

Read More
long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands